{name}
{subtitle}
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
city
~96 mi. (Bucharest, Romania, +158 more cities)
facility
Spitalul Universitar de Urgenta Bucuresti ( Site 2508)
drug
olaparib, +4 more drugs
drug type
chemotherapy, +3 more types